Binnopharm Group places bonds worth 2 billion roubles for the third time this year

Leading pharmaceutical company Binnopharm Group successfully placed third bond issue in 2025. The issue volume totalled to 2 billion roubles, with a maximum coupon rate of 19.5% and monthly payments. The updated terms of the bond issue have been developed in line with current market conditions and investor interest. The issue was executed in a “club” format, illustrating the strong interest of institutional investors in the company’s securities.

Khafiz Gafurov, Chief Financial Officer of Binnopharm Group: «This Binnopharm Group’s bond placement is a unique one since it was executed in a ‘club’ format in the shortest possible timeframe at a rate below current market levels for bonds with a similar credit rating».

The 001P-06 series bonds have been assigned a credit rating of ruA(EXP) by the Expert RA rating agency, being a testament to the company’s stable financial position and its high ability to fulfil its obligations to investors.

The funds raised will be allocated to investments in the company’s major projects, including the launch of monoclonal antibody based products manufacturing, the construction of a large pharmaceutical warehouse in the Urals, etc.

During the second part of this year, Binnopharm Group will continue to optimise its loan portfolio by utilising the most effective financial instruments.